Dr. Arora is an Associate Professor in the College of Community Health Sciences (CCHS). Her ability to learn new concepts quickly, and motivation to solve problems regardless of difficulty serve her well in research. Her current interest is receptor-mediated drug delivery stemmed from the fact that complex mixtures can be separated using chromatographic techniques, a topic she earned her PhD for. She serves as a CO-PI on two NIH R01 grants.
- Novel oral nanoparticle formulation of sustained release naloxone with mild withdrawal symptoms in a mouse model, C. Madison, M. Arora, M. N. V. Ravi Kumar, S. Eitan. N. ACS Chem. Neurosci. 11: 1955–1964, 2020.
- Next-generation non-competitive nanosystems based on gambogic acid: in silico identification of transferrin receptor binding sites, regulatory shelf-stability and their preliminary safety in healthy rodents, M. Arora, R. Ganugula, N. Kumar, G. Kaur, J.-P. Pellois, P. Garg, M. N. V. Ravi Kumar. ACS Appl. Bio Mater. 2: 3540-3550, 2019.
- Double-headed nanosystems for oral drug delivery, G. Kaur, M. Arora, R. Ganugula and M. N. V. Ravi Kumar. Chem Comm. 55: 4761-4764, 2019.
- Non-competitive active transport exploiting intestinal transferrin receptors for oral delivery of proteins by tunable nano-platform, R. Ganugula, M. Arora, M. Guada, P. Saini and M. N.V. Ravi Kumar. ACS Macro Lett. 6: 161-164, 2017.
- The next generation non-competitive active polyester nanosystems for transferrin receptor-mediated peroral transport utilizing gambogic acid as a ligand, P. Saini, R. Ganugula, M. Arora, M. N. V. Ravi Kumar. Sci. Rep. 6, 29501, 2016
Over the years, she has been involved in transdisciplinary research settings that involve bioanalytical & supramolecular chemistry, and toxicology. Her current research involves bespoke polyester synthesis for customized receptor-mediated drug delivery or otherwise, and their use in treating various human and veterinary diseases.